# Peptides Studied for Sleep Apnea: The Trials | PepVault

Source: https://pepvault.app/conditions/sleep-apnea

Last updated: 2026-11-19

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Research](https://pepvault.app/research) [By condition](https://pepvault.app/conditions) Sleep Apnea

Peptides by condition · Heart, kidneys and lungs

# Peptides studied for obstructive sleep apnea

Checked November 2026 against our study pages and the FDA labels [Published by PepVault](https://pepvault.app/guides/how-we-research)

Our library holds 4 study pages on obstructive sleep apnea: 4 in people (all meta-analyses or randomized trials). They studied 2 compounds, with this many study pages each: Tirzepatide 3 and Retatrutide 1.

## What the research on obstructive sleep apnea looks like

Obstructive sleep apnea is breathing that stops and starts during sleep because the throat closes, again and again through the night. It is closely tied to excess weight, which narrows the airway, and it leaves people tired by day and strains the heart and blood pressure. The peptide research on it comes from weight-loss trials of the newer GLP-1 drugs in adults with obesity and sleep apnea.

Sleep apnea trials count the apnea-hypopnea index (AHI), how many times an hour breathing stops or turns shallow, in an overnight sleep study. They also ask about sleepiness, daytime function and quality of life on questionnaires, and some measure how much oxygen in the blood dropped during the night.

These were trials of weight-loss drugs, so check how much of the change in breathing followed the weight lost. Some people in them used a CPAP machine, the mask that keeps the airway open at night, and some did not; the trials looked at those groups separately, and a result in one may not hold in the other. A subgroup of a larger trial is weaker evidence than a trial built for sleep apnea.

How many of the 4 study pages on this condition reach each design, strongest at the top: meta-analyses and randomized trials in people, other studies in people, animals, cells.

<!--promo-->

Model. Individual results vary.

PepVault for iPhone

## Track your own progress in PepVault

Doses, vials, weight and side effects in one log.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=conditions-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## The 4 studies, by compound

Grouped by the compound each study is filed under, and within each, strongest design first. Each line gives the design, who was studied, how many and the year, before the finding.

1. ### [Tirzepatide](https://pepvault.app/peptides/tirzepatide)

   3 in people

   For obstructive sleep apnea, 3 of our study pages are filed under Tirzepatide: 3 randomized trials in people. Its studies in people do not give their size on our pages. They were published from 2024 to 2025, in Sleep Med and N Engl J Med.

   FDA-approved, with a use tied to obstructive sleep apnea on its label: Zepbound (injection) for weight loss and keeping it off, and moderate to severe obstructive sleep apnea in adults with obesity. Under Mounjaro it is approved for other uses.

   - Randomized trial in people · 2025 [Tirzepatide: sleep apnea gains beat placebo by week 20 in SURMOUNT-OSA](https://pepvault.app/research/tirzepatide-surmount-osa-2025)
   - Randomized trial in people · 2025 [Tirzepatide: better sleep and quality of life scores in SURMOUNT-OSA](https://pepvault.app/research/tirzepatide-surmount-osa-2025-40774158)
   - Randomized trial in people · 2024 [Tirzepatide: AHI fell 25.3 and 29.3 events per hour in SURMOUNT-OSA](https://pepvault.app/research/tirzepatide-surmount-osa-2024)

   - [Zepbound, from its FDA label](https://pepvault.app/drugs/zepbound)
   - [Tirzepatide: legal and regulatory status](https://pepvault.app/peptides/tirzepatide/legal-status)
   - [Tirzepatide in the library](https://pepvault.app/peptides/tirzepatide)
   - [Tirzepatide dose guide](https://pepvault.app/lab/dosage/tirzepatide)
2. ### [Retatrutide](https://pepvault.app/peptides/retatrutide)

   1 in people

   For obstructive sleep apnea, 1 of our study pages is filed under Retatrutide: 1 randomized trial in people. It enrolled 2,339 people and was published in 2026, in N Engl J Med.

   Retatrutide has no FDA-approved product: Drugs@FDA lists no application for it, and FDA writes that it is not a component of any FDA-approved drug.

   - Randomized trial in people · 2,339 people · 2026 [Retatrutide: up to 25.0% weight loss at 80 weeks in TRIUMPH-1](https://pepvault.app/research/retatrutide-triumph-1-2026)

   - [Retatrutide: legal and regulatory status](https://pepvault.app/peptides/retatrutide/legal-status)
   - [Retatrutide in the library](https://pepvault.app/peptides/retatrutide)
   - [Retatrutide dose guide](https://pepvault.app/lab/dosage/retatrutide)

## On obstructive sleep apnea

### Tirzepatide

- [Tirzepatide: the full reference](https://pepvault.app/peptides/tirzepatide)
- [Tirzepatide dose guide](https://pepvault.app/lab/dosage/tirzepatide)

### Retatrutide

- [Retatrutide: the full reference](https://pepvault.app/peptides/retatrutide)
- [Retatrutide dose guide](https://pepvault.app/lab/dosage/retatrutide)

### Mixing charts

- [Tirzepatide 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-5mg)
- [Tirzepatide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-10mg)
- [Tirzepatide 15 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-15mg)
- [Tirzepatide 30 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-30mg)
- [Tirzepatide 60 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-60mg)
- [Retatrutide 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/retatrutide-5mg)
- [Retatrutide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/retatrutide-10mg)
- [Retatrutide 15 mg vial](https://pepvault.app/tools/reconstitution-calculator/retatrutide-15mg)

### Studies

- [Tirzepatide plus apitegromab: 1.9 kg less lean mass loss in EMBRAZE](https://pepvault.app/research/tirzepatide-embraze-2026)
- [Tirzepatide SURMOUNT-MAINTAIN: 21.9% weight loss at 112 weeks](https://pepvault.app/research/tirzepatide-surmount-maintain-2026)
- [Dulaglutide: switching to tirzepatide beat dose escalation on HbA1c](https://pepvault.app/research/dulaglutide-surpass-switch-2025)
- [All 19 studies](https://pepvault.app/research#tirzepatide)
- [Retatrutide: systolic blood pressure down 6.79 mmHg in meta-analysis](https://pepvault.app/research/retatrutide-simental-mendia-2026)
- [Retatrutide: top odds of 15% or more weight loss across 19 trials](https://pepvault.app/research/retatrutide-sinha-2025)
- [Retatrutide: non-HDL cholesterol down up to 26.9% in phase 2 trials](https://pepvault.app/research/retatrutide-ruotolo-2026)
- [All 16 studies](https://pepvault.app/research#retatrutide)

### Compared with

- [Retatrutide vs Tirzepatide](https://pepvault.app/peptides/compare/retatrutide-vs-tirzepatide)
- [Semaglutide vs Tirzepatide](https://pepvault.app/peptides/compare/semaglutide-vs-tirzepatide)
- [Mazdutide vs Tirzepatide](https://pepvault.app/peptides/compare/mazdutide-vs-tirzepatide)
- [Tirzepatide vs Liraglutide](https://pepvault.app/peptides/compare/tirzepatide-vs-liraglutide)
- [Tirzepatide vs Dulaglutide](https://pepvault.app/peptides/compare/tirzepatide-vs-dulaglutide)
- [Orforglipron vs Tirzepatide](https://pepvault.app/peptides/compare/orforglipron-vs-tirzepatide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)
- [GLP-1 titration planner](https://pepvault.app/tools/glp1-titration-calculator)
- [GLP-1 weight loss by week](https://pepvault.app/tools/glp1-weight-loss-by-week)

### Related conditions

- [Peptides studied for obesity](https://pepvault.app/conditions/obesity)
- [Peptides studied for knee pain and osteoarthritis](https://pepvault.app/conditions/knee-osteoarthritis)
- [Peptides studied for type 2 diabetes](https://pepvault.app/conditions/type-2-diabetes)
- [Peptides studied for fatty liver disease (MASH)](https://pepvault.app/conditions/fatty-liver-disease)

### By goal

- [Peptides for weight loss](https://pepvault.app/peptides/for/weight-loss)
- [Peptides for sleep](https://pepvault.app/peptides/for/sleep)

### Terms on this page

- [Peptide](https://pepvault.app/glossary/peptide)
- [GLP-1](https://pepvault.app/glossary/glp-1)

## Side by side

For the 2 compounds on this page: studies in people, studies in animals or cells, the size of the largest study in people, and the FDA status from the labels our status pages read (a dash where they hold no record).

| Compound | In people | Animals or cells | Largest in people | FDA |
| --- | --- | --- | --- | --- |
| [Tirzepatide](https://pepvault.app/peptides/tirzepatide) | 3 | 0 | — | Approved, a use tied to it |
| [Retatrutide](https://pepvault.app/peptides/retatrutide) | 1 | 0 | 2,339 | Not approved |

## What the studies did not show

Each study page names its own limits. These are the questions still open, in the study pages’ words.

- [Tirzepatide: sleep apnea gains beat placebo by week 20 in SURMOUNT-OSA](https://pepvault.app/research/tirzepatide-surmount-osa-2025) This was a post hoc analysis, so it was not the trial's main test. It shows that improvement went along with weight loss, but it could not separate the effect of weight loss from other effects of tirzepatide. The authors say more research is needed on that question.
- [Tirzepatide: better sleep and quality of life scores in SURMOUNT-OSA](https://pepvault.app/research/tirzepatide-surmount-osa-2025-40774158) These are self-reported questionnaire results over 52 weeks in people with moderate-to-severe sleep apnea and obesity, so they may not apply to milder sleep apnea or to people without obesity. The sleepiness result was significant in Study 1 only.
- [Retatrutide: up to 25.0% weight loss at 80 weeks in TRIUMPH-1](https://pepvault.app/research/retatrutide-triumph-1-2026) The trial included only adults without diabetes, and the knee and sleep apnea results come from smaller subgroups. It was funded by Eli Lilly.

This page is a reading of published studies, not medical advice. A diagnosis, and what to do about it, is a conversation with a clinician.

## Related pages

- [Peptides studied for obesity 3 studies in common](https://pepvault.app/conditions/obesity)
- [Peptides studied for knee pain and osteoarthritis 1 study in common](https://pepvault.app/conditions/knee-osteoarthritis)
- [Peptides studied for type 2 diabetes 2 compounds in common](https://pepvault.app/conditions/type-2-diabetes)
- [Peptides studied for fatty liver disease (MASH) 2 compounds in common](https://pepvault.app/conditions/fatty-liver-disease)

### By goal

- [Peptides for weight loss](https://pepvault.app/peptides/for/weight-loss)
- [Peptides for sleep](https://pepvault.app/peptides/for/sleep)

### Trial terms

- [Randomized controlled trial (RCT)](https://pepvault.app/glossary/randomized-controlled-trial)
- [Placebo](https://pepvault.app/glossary/placebo)
- [Phase 1, 2 and 3 trials](https://pepvault.app/glossary/clinical-trial-phases)
- [Meta-analysis](https://pepvault.app/glossary/meta-analysis)

## Questions

### Which peptides have been studied for obstructive sleep apnea?

Our 4 study pages on obstructive sleep apnea are filed under 2 compounds, with this many each: Tirzepatide 3 and Retatrutide 1. Tirzepatide has the most.

### Have any been tested in people with obstructive sleep apnea?

Yes: all 4 were in people, all of them meta-analyses or randomized trials (Tirzepatide and Retatrutide). The largest enrolled 2,339 people: “Retatrutide: up to 25.0% weight loss at 80 weeks in TRIUMPH-1” (2026).

### Is any peptide FDA-approved for obstructive sleep apnea?

Yes, with a use tied to obstructive sleep apnea on their FDA labels: Tirzepatide as Zepbound. 1 other compound here with an FDA record has no use tied to it.

### How large were the studies in people on obstructive sleep apnea?

Of the 4 in people, 1 gives its size on our pages: 1 had 1,000 people or more. The largest, a randomized trial from 2026, enrolled 2,339.

### What is the newest study on obstructive sleep apnea here?

Of our study pages on obstructive sleep apnea, the newest is “Retatrutide: up to 25.0% weight loss at 80 weeks in TRIUMPH-1”, a randomized trial in people published in 2026.

## How this page was built

A study page is listed here only where we read its question, design and finding and the study was about this condition: its subjects had the condition, or were an animal or cell model of it, and the study gave them the compound. A study that only mentions the condition is not listed.

Studies are grouped by the compound each is filed under and ordered by design: meta-analyses and randomized trials in people first, then other studies in people, then animals, then cells, and within a group by size and then by year. The FDA status comes from the labels our legal-status and brand pages read.

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=conditions-card-next&mt=8)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Track your own progress in PepVault

Doses, vials, weight and side effects in one log.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=conditions-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

<!--promo-->

Model. Individual results vary.

PepVault for iPhone

## Track your own progress in PepVault

Doses, vials, weight and side effects in one log.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=conditions-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## On obstructive sleep apnea

### Tirzepatide

- [Tirzepatide: the full reference](https://pepvault.app/peptides/tirzepatide)
- [Tirzepatide dose guide](https://pepvault.app/lab/dosage/tirzepatide)

### Retatrutide

- [Retatrutide: the full reference](https://pepvault.app/peptides/retatrutide)
- [Retatrutide dose guide](https://pepvault.app/lab/dosage/retatrutide)

### Mixing charts

- [Tirzepatide 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-5mg)
- [Tirzepatide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-10mg)
- [Tirzepatide 15 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-15mg)
- [Tirzepatide 30 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-30mg)
- [Tirzepatide 60 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-60mg)
- [Retatrutide 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/retatrutide-5mg)
- [Retatrutide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/retatrutide-10mg)
- [Retatrutide 15 mg vial](https://pepvault.app/tools/reconstitution-calculator/retatrutide-15mg)

### Studies

- [Tirzepatide plus apitegromab: 1.9 kg less lean mass loss in EMBRAZE](https://pepvault.app/research/tirzepatide-embraze-2026)
- [Tirzepatide SURMOUNT-MAINTAIN: 21.9% weight loss at 112 weeks](https://pepvault.app/research/tirzepatide-surmount-maintain-2026)
- [Dulaglutide: switching to tirzepatide beat dose escalation on HbA1c](https://pepvault.app/research/dulaglutide-surpass-switch-2025)
- [All 19 studies](https://pepvault.app/research#tirzepatide)
- [Retatrutide: systolic blood pressure down 6.79 mmHg in meta-analysis](https://pepvault.app/research/retatrutide-simental-mendia-2026)
- [Retatrutide: top odds of 15% or more weight loss across 19 trials](https://pepvault.app/research/retatrutide-sinha-2025)
- [Retatrutide: non-HDL cholesterol down up to 26.9% in phase 2 trials](https://pepvault.app/research/retatrutide-ruotolo-2026)
- [All 16 studies](https://pepvault.app/research#retatrutide)

### Compared with

- [Retatrutide vs Tirzepatide](https://pepvault.app/peptides/compare/retatrutide-vs-tirzepatide)
- [Semaglutide vs Tirzepatide](https://pepvault.app/peptides/compare/semaglutide-vs-tirzepatide)
- [Mazdutide vs Tirzepatide](https://pepvault.app/peptides/compare/mazdutide-vs-tirzepatide)
- [Tirzepatide vs Liraglutide](https://pepvault.app/peptides/compare/tirzepatide-vs-liraglutide)
- [Tirzepatide vs Dulaglutide](https://pepvault.app/peptides/compare/tirzepatide-vs-dulaglutide)
- [Orforglipron vs Tirzepatide](https://pepvault.app/peptides/compare/orforglipron-vs-tirzepatide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)
- [GLP-1 titration planner](https://pepvault.app/tools/glp1-titration-calculator)
- [GLP-1 weight loss by week](https://pepvault.app/tools/glp1-weight-loss-by-week)

### Related conditions

- [Peptides studied for obesity](https://pepvault.app/conditions/obesity)
- [Peptides studied for knee pain and osteoarthritis](https://pepvault.app/conditions/knee-osteoarthritis)
- [Peptides studied for type 2 diabetes](https://pepvault.app/conditions/type-2-diabetes)
- [Peptides studied for fatty liver disease (MASH)](https://pepvault.app/conditions/fatty-liver-disease)

### By goal

- [Peptides for weight loss](https://pepvault.app/peptides/for/weight-loss)
- [Peptides for sleep](https://pepvault.app/peptides/for/sleep)

### Terms on this page

- [Peptide](https://pepvault.app/glossary/peptide)
- [GLP-1](https://pepvault.app/glossary/glp-1)

<!--promo-->

PepVault for iPhone

## Track your own progress in PepVault

Doses, vials, weight and side effects in one log.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=conditions-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## By condition

- [Every condition](https://pepvault.app/conditions)
- [Peptides studied for obesity](https://pepvault.app/conditions/obesity)
- [Peptides studied for knee pain and osteoarthritis](https://pepvault.app/conditions/knee-osteoarthritis)
- [Peptides studied for type 2 diabetes](https://pepvault.app/conditions/type-2-diabetes)
- [Peptides studied for fatty liver disease (MASH)](https://pepvault.app/conditions/fatty-liver-disease)

## The research

- [Studies, in plain English](https://pepvault.app/research)
- [The peptide reference library](https://pepvault.app/peptides)
- [Peptides by goal](https://pepvault.app/peptides/for)

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
